Mersana Therapeutics Stock (NASDAQ: MRSN) stock price, news, charts, stock research, profile.
You can purchase shares of Mersana Therapeutics (NASDAQ:MRSN) through any online brokerage.
Other companies in Mersana Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Gain Therapeutics (NASDAQ:GANX), Burning Rock Biotech (NASDAQ:BNR) and Armata Pharmaceuticals (AMEX:ARMP).
Mersana Therapeutics has a consensus price target of $6.38.
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $0.5398 last updated February 21, 2025 at 7:13 PM EST.
There are no upcoming dividends for Mersana Therapeutics.
Mersana Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Mersana Therapeutics.
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.